TEGER

Technology platform to identify, develop and deliver gene therapy vectors to combat genetic kidney diseases: Treatment of autosomal dominant polycystic disease type II 

TEGER refers to the search for innovative solutions for hereditary kidney diseases in Navarre through the development of advanced therapies based on mass sequencing and focused on the mutations that cause polycystic kidney disease, with gender taken into consideration throughout the research.